Startups
Sulfagenix holds the key unlocking the regenerating abilities of the body.
Sulfagenix, Inc. is built on decades of research on modifying existing molecules to improve safety, bioavailability and efficacy for new uses.
SG1002 (sodium polysulthionate), Sulfagenix’s clinical-stage prodrug, is a precursor to a natural-occurring molecule, hydrogen sulfide, for which deficits have been shown to exist in a number of serious diseases, including cardiovascular disease.
Sulfagenix, Inc. is built on decades of research on modifying existing molecules to improve safety, bioavailability and efficacy for new uses.
SG1002 (sodium polysulthionate), Sulfagenix’s clinical-stage prodrug, is a precursor to a natural-occurring molecule, hydrogen sulfide, for which deficits have been shown to exist in a number of serious diseases, including cardiovascular disease.
Overview
Employees
1-10
Founded date
2011
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Drug startup Sulfagenix uses small amounts of hydrogen sulfide to stymie damage to the heart | In high concentrations, hydrogen sulfide is highly poisonous. But in the small amounts naturally produced by the body, researchers have found that it actually provides many benefits to humans. “Through our work and the work of others, we kn... |